Table 3.
Total N (%) (N=69)a |
Non-BED n (%) (n=52)b |
BED n (%) (n=17)c |
Chi-Square Analyses | |
---|---|---|---|---|
Metabolic Syndrome Diagnosis at Baseline |
26 (35.1%)a | 20 (37.0%)b | 6 (30.0%)c | X2(1)=0.32, p = 0.573 |
Metabolic Syndrome Diagnosis at Post-Treatment |
18 (26.1%) | 10 (19.2%) | 8 (47.1%) | X2(1)=5.145, p = 0.023, phi =.273 |
Change in Metabolic Syndrome Diagnosis from Baseline to Post-Treatment |
X2(1)=6.219, p = 0.045, phi =.300 | |||
No Change | 51 (73.9%) | 37 (71.2%) | 14 (82.4%) | |
New Diagnosis | 6 (8.7%) | 3 (5.8%) | 3 (17.6%) | |
Improvement | 12 (17.4%) | 12 (23.1%) | 0 (0.0%) |
Note. n=54 at baseline.
n=54 at baseline.
n=20 at baseline.